Thrombospondine 1 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Thrombospondine 1" in French language version.

refsWebsite

Global rank French rank

3ahajournals.org

3,608^th place

659^th place

1,626^th place

2,018^th place

4^th place

12^th place

222^nd place

129^th place

2sciencedirect.com

149^th place

80^th place

485^th place

416^th place

ahajournals.org

atvb.ahajournals.org

Csányi G, Yao M, Rodríguez AI et al. Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1, Arterioscler Thromb Vasc Biol, 2012;32:2966–2973
Moura R, Tjwa M, Vandervoort P, Cludts K, Hoylaerts MF, Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation, Arterioscler Thromb Vasc Biol, 2007;27:2163–2169.

circ.ahajournals.org

Kim CW, Pokutta-Paskaleva A, Kumar S et al. Disturbed flow promotes arterial stiffening through thrombospondin-1, Circulation, 2017;136:1217-1232

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000137801 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000040152 - Ensembl, May 2017

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine

oup.com

academic.oup.com

Rogers NM, Sharifi-Sanjani M, Yao M et al. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction, Cardiovasc Res, 2017;113:15–29

sciencedirect.com

Crawford SE, Stellmach V, Murphy-Ullrich JE et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo, Cell, 1998;93:1159–1170
Sweetwyne MT, Murphy-Ullrich JE, Thrombospondin1 in tissue repair and fibrosis: TGF-β-dependent and independent mechanisms, Matrix Biol, 2012;31:178–186

wiley.com

onlinelibrary.wiley.com

Mustonen E, Ruskoaho H, Rysä J, Thrombospondins, potential drug targets for cardiovascular diseases, Basic Clin Pharmacol Toxicol, 2013;112:4–12
Favier J, Germain S, Emmerich J, Corvol P, Gasc JM, Critical overexpression of thrombospondin 1 in chronic leg ischaemia, J Pathol, 2005;207:358–366